Table 1.
Pre- to post-intervention changes in lower-limb volume and symptoms in patients with secondary lymphedema
| Outcomes | Mean percentage change (95% CI) | P | |||||
|---|---|---|---|---|---|---|---|
| Seated AECT | Supine AECT | CT | P1 | P2 | P3 | Overall P value | |
| Lower-limb volume |
1.19% ± 1.32% (0.62–1.76%) |
2.03% ± 1.24% (1.46–2.60%) |
0.99% ± 0.83% (0.42–1.56%) |
1.00 | 0.01 | 0.06 | 0.01 |
| Pain |
27.9% ± 53.2% (8.95–46.87%) |
71.0% ± 22.4% (52.08–89.99%) |
45.4% ± 28.8% (26.44–64.35%) |
0.41 | 0.10 | 0.02 | 0.03 |
| Heaviness |
27.5% ± 63.6% (6.34–48.69%) |
62.3% ± 26.2% (41.16–83.51%) |
57.6% ± 27.6% (36.47–78.82%) |
0.07 | 1.00 | 0.03 | 0.02 |
Note. Mean percentage changes in the least square mean (LSM) values were estimated on the basis of analyses of variance using linear mixed-effect modeling. LSM changes in lower limb volume and percentage changes in general symptoms of pain and heaviness were calculated as effects of the intervention.
P1, seated AECT versus CT; P2, supine AECT versus CT; P3, seated AECT versus supine AECT, AECT, active exercise with compression therapy; seated AECT, AECT in a seated position; supine AECT, AECT in a supine position; CT, compression-only therapy